Cargando…
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229471/ https://www.ncbi.nlm.nih.gov/pubmed/32425661 http://dx.doi.org/10.1016/j.jcv.2020.104443 |
| _version_ | 1783534770132615168 |
|---|---|
| author | Hassoun, Ali Thottacherry, Elizabeth Dilip Muklewicz, Justin Aziz, Qurrat-ul-ain Edwards, Jonathan |
| author_facet | Hassoun, Ali Thottacherry, Elizabeth Dilip Muklewicz, Justin Aziz, Qurrat-ul-ain Edwards, Jonathan |
| author_sort | Hassoun, Ali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7229471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72294712020-05-18 Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 Hassoun, Ali Thottacherry, Elizabeth Dilip Muklewicz, Justin Aziz, Qurrat-ul-ain Edwards, Jonathan J Clin Virol Article Elsevier B.V. 2020-07 2020-05-16 /pmc/articles/PMC7229471/ /pubmed/32425661 http://dx.doi.org/10.1016/j.jcv.2020.104443 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Hassoun, Ali Thottacherry, Elizabeth Dilip Muklewicz, Justin Aziz, Qurrat-ul-ain Edwards, Jonathan Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title | Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title_full | Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title_fullStr | Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title_full_unstemmed | Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title_short | Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19 |
| title_sort | utilizing tocilizumab for the treatment of cytokine release syndrome in covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229471/ https://www.ncbi.nlm.nih.gov/pubmed/32425661 http://dx.doi.org/10.1016/j.jcv.2020.104443 |
| work_keys_str_mv | AT hassounali utilizingtocilizumabforthetreatmentofcytokinereleasesyndromeincovid19 AT thottacherryelizabethdilip utilizingtocilizumabforthetreatmentofcytokinereleasesyndromeincovid19 AT muklewiczjustin utilizingtocilizumabforthetreatmentofcytokinereleasesyndromeincovid19 AT azizqurratulain utilizingtocilizumabforthetreatmentofcytokinereleasesyndromeincovid19 AT edwardsjonathan utilizingtocilizumabforthetreatmentofcytokinereleasesyndromeincovid19 |